June 2019 - Ammonium Ion Binding Activity drug patent information, international generic entry, market access

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Medicis	AMMONUL	sodium benzoate; sodium phenylacetate	SOLUTION;INTRAVENOUS	020645-001	Feb 17, 2005	AP	RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Horizon Therap	BUPHENYL	sodium phenylbutyrate	TABLET;ORAL	020572-001	May 13, 1996	AB	RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Horizon Therap	BUPHENYL	sodium phenylbutyrate	POWDER;ORAL	020573-001	Apr 30, 1996	AB	RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Ailex Pharms Llc	SODIUM PHENYLACETATE AND SODIUM BENZOATE	sodium benzoate; sodium phenylacetate	SOLUTION;INTRAVENOUS	207096-001	Feb 24, 2016	AP	RX	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Maia Pharms Inc	SODIUM PHENYLACETATE AND SODIUM BENZOATE	sodium benzoate; sodium phenylacetate	SOLUTION;INTRAVENOUS	208521-001	May 8, 2017	AP	RX	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Navinta Llc	SODIUM PHENYLACETATE AND SODIUM BENZOATE	sodium benzoate; sodium phenylacetate	SOLUTION;INTRAVENOUS	205880-001	Aug 4, 2016	AP	RX	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Sigmapharm Labs Llc	SODIUM PHENYLBUTYRATE	sodium phenylbutyrate	POWDER;ORAL	202819-001	Mar 22, 2013	AB	RX	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration